ArticleLeukemia2015

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.

P Macor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.